Liran Einav
Overview
Explore the profile of Liran Einav including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Einav L, Finkelstein A
Ann Intern Med
. 2024 May;
177(6):812-816.
PMID: 38739923
The current U.S. health insurance "system" was not deliberately planned and constructed but has emerged piecemeal over the past half-century through a series of incremental and haphazard reforms. That policy...
2.
Zeltzer D, Einav L, Rashba J, Waisman Y, Haimi M, Balicer R
J Health Econ
. 2023 Jun;
90:102780.
PMID: 37331155
We estimate the effect of adopting a digital device for performing medical exams at home during telehealth visits. We match visits of adopters and non-adopters who used the same virtual...
3.
Einav L, Finkelstein A
Proc Natl Acad Sci U S A
. 2023 Apr;
120(18):e2222100120.
PMID: 37094163
Health insurance coverage in the United States is highly uncertain. In the post-Affordable Care Act (ACA), pre-COVID United States, we estimate that while 12.5% of individuals under 65 are uninsured...
4.
Ji Y, Einav L, Mahoney N, Finkelstein A
JAMA Health Forum
. 2022 Oct;
3(10):e223503.
PMID: 36206005
Importance: Home dialysis rates for end-stage kidney disease (ESKD) treatment are substantially lower in the US than in other high-income countries, yet there is limited knowledge on how to increase...
5.
Einav L, Finkelstein A, Ji Y, Mahoney N
Q J Econ
. 2022 Mar;
137(1):565-618.
PMID: 35233120
Government programs are often offered on an optional basis to market participants. We explore the economics of such voluntary regulation in the context of a Medicare payment reform, in which...
6.
Einav L, Finkelstein A, Oostrom T, Ostriker A, Williams H
Am Econ Rev
. 2021 Jul;
110(12):3836-3870.
PMID: 34305149
We analyze selection into screening in the context of recommendations that breast cancer screening start at age 40. Combining medical claims with a clinical oncology model, we document that compliers...
7.
Zeltzer D, Einav L, Chasid A, Balicer R
J Health Econ
. 2021 May;
78:102453.
PMID: 33964651
We study the role of person- and place-specific factors in explaining geographic variation in emergency department utilization using detailed data on 150,000 patients who moved regions within Israel. We document...
8.
Zhang J, Chen Y, Einav L, Levin J, Bhattacharya J
Health Econ
. 2021 Mar;
30(6):1361-1373.
PMID: 33764640
We use administrative data from Medicare to document the massive consolidation of primary care physicians over the last decade and its impact on patient healthcare utilization. We first document that...
9.
Miron O, Zeltzer D, Shir T, Balicer R, Einav L, Feldman B
Reg Anesth Pain Med
. 2020 Nov;
46(5):455-456.
PMID: 33214218
No abstract available.
10.
Einav L, Finkelstein A, Ji Y, Mahoney N
Proc Natl Acad Sci U S A
. 2020 Jul;
117(32):18939-18947.
PMID: 32719129
Changes in the way health insurers pay healthcare providers may not only directly affect the insurer's patients but may also affect patients covered by other insurers. We provide evidence of...